Source-grounded facts extracted from HEALTHPEAK PROPERTIES, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
HEALTHPEAK PROPERTIES, INC. updated its the first quarter and three months ended March 31, 2026 guidance (raised).
“On May 5, 2026, Healthpeak Properties, Inc., a Maryland corporation (“Healthpeak”), issued a press release setting forth its financial results for the first quarter and three months ended March 31, 2026.”
HEALTHPEAK PROPERTIES, INC. amended credit facility of $2.0 billion with Bank of America, N.A. (as administrative agent).
“maximum aggregate borrowing capacity under the Healthpeak Term Loan Credit Agreement was increased from $1.5 billion to $2.0 billion”
HEALTHPEAK PROPERTIES, INC. incurred term loan of $400.0 million with Bank of America, N.A. (as administrative agent) at applicable margin plus base rate, Term SOFR or Daily SOFR maturing five years.
“Healthpeak OP obtained senior unsecured delayed draw term loan commitments in an aggregate principal amount of $400.0 million with a stated maturity of five years”
Kelvin O. Moses was appointed as Chief Financial Officer at HEALTHPEAK PROPERTIES, INC..
“On April 24, 2025, the Board of Directors of Healthpeak Properties, Inc. (the “Company”) appointed Kelvin O. Moses as the Company’s Chief Financial Officer and principal financial officer, effective immediately, pursuant to the Company’s succession plan.”
Peter A. Scott resigned as Chief Financial Officer at HEALTHPEAK PROPERTIES, INC..
“On April 2, 2025, Peter A. Scott informed Healthpeak Properties, Inc. (the “Company”) of his resignation from his position as Chief Financial Officer of the Company.”
Thomas Klaritch departed as Chief Operating Officer at HEALTHPEAK PROPERTIES, INC..
“Thomas Klaritch, currently the Company’s Chief Operating Officer, will retire from the Company.”
HEALTHPEAK PROPERTIES, INC. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year ending December 31, 2024 at the 2024-04-25 meeting.
“Proposal 3 . The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, was approved. For Against Abstain Broker Non-Votes % of Votes Cast Supporting 620,953,588 14,829,272 459,396 N/A 97.67 %”
HEALTHPEAK PROPERTIES, INC. shareholders approved Advisory vote to approve 2023 executive compensation at the 2024-04-25 meeting.
“Proposal 2 . The advisory vote to approve 2023 executive compensation was approved. For Against Abstain Broker Non-Votes % of Votes Cast Supporting 548,270,776 38,235,408 873,572 48,862,500 93.48 %”
HEALTHPEAK PROPERTIES, INC. shareholders approved Election of Directors at the 2024-04-25 meeting.
“Proposal 1 . All of the nominees listed below were elected to the Board of Directors of the Company, each having received the affirmative vote of a majority of the votes cast. For Against Abstain Broker Non-Votes % of Votes Cast Supporting Scott M. Brinker 582,831,626 4,068,380 479,750 48,862,500 99.31 % Katherine M. Sandstrom 553,781,817 33,118,908 479,031 48,862,500 94.36 % John T. Thomas 583,191,586 3,710,222 477,948 48,862,500 99.37 % Brian G. Cartwright 578,484,811 8,390,456 504,489 48,862,500 98.57 % James B. Connor 579,928,038 6,962,013 489,705 48,862,500 98.81 % R. Kent Griffin, Jr. 579,229,541 7,662,898 487,317 48,862,500 98.69 % Pamela J. Kessler 583,698,642 3,222,110 459,004 48,862,500 99.45 % Sara G. Lewis 566,873,595 20,035,240 470,921 48,862,500 96.59 % Ava E. Lias-Booker 583,544,342 3,331,289 504,125 48,862,500 99.43 % Tommy G. Thompson 582,923,497 3,962,088 494,171 48,862,500 99.32 % Richard A. Weiss 583,029,763 3,864,720 485,273 48,862,500 99.34 %”
David B. Henry retired as Director at HEALTHPEAK PROPERTIES, INC..
“Christine N. Garvey and David B. Henry retired from the Board of Directors (the “Board”) of Healthpeak Properties, Inc. (the “Company”) effective immediately prior to the 2024 annual meeting of stockholders held on April 25, 2024 (the “Annual Meeting”).”
Christine N. Garvey retired as Director at HEALTHPEAK PROPERTIES, INC..
“Christine N. Garvey and David B. Henry retired from the Board of Directors (the “Board”) of Healthpeak Properties, Inc. (the “Company”) effective immediately prior to the 2024 annual meeting of stockholders held on April 25, 2024 (the “Annual Meeting”).”
HEALTHPEAK PROPERTIES, INC. reported the three months ended March 31, 2024 results: net income $0.01 per share. Guidance raised.
“Healthpeak Properties, Inc., a Maryland corporation (“Healthpeak”), issued a press release setting forth its financial results for the three months ended March 31, 2024.”
HEALTHPEAK PROPERTIES, INC. amended Sales Agreement with J.P. Morgan Securities LLC, Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanle valued at up to $1,500,000,000 (effective 2024-03-11).
“On March 11, 2024, Healthpeak Properties, Inc., a Maryland corporation (the “Company”), and Healthpeak OP, LLC, a Maryland limited liability company (the “operating company”), entered into an amendment (the “Amendment”) to the “at-the market” equity offering sales agreement (the “Sales Agreement”) with each of J.P. Morgan Securities LLC, Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC”
HEALTHPEAK PROPERTIES, INC.: Increased maximum number of directors to thirteen (effective 2024-02-28).
“to increase the maximum number of directors of the Board to thirteen members”
HEALTHPEAK PROPERTIES, INC.: Increased authorized shares of common stock from 750,000,000 to 1,500,000,000 (effective 2024-02-29).
“increases the authorized number of shares of Healthpeak Common Stock from a total of 750,000,000 to 1,500,000,000.”
HEALTHPEAK PROPERTIES, INC. entered into Revolver Amendment with Bank of America, N.A. valued at Consent and Amendment No. 2 and Joinder to Second Amended and Restated Credit Agreement (effective 2024-03-01).
“On the Closing Date, concurrently with the consummation of the Mergers, Healthpeak OP and Healthpeak entered into (a) the Consent and Amendment No. 2 and Joinder (the " Revolver Amendment ") to its Second Amended and Restated Credit Agreement, dated as of September 20, 2021, by and among Healthpeak OP, Healthpeak, DOC DR Holdco, DOC DR OP Sub, the lenders party thereto and Bank of America, N.A., as administrative agent”
HEALTHPEAK PROPERTIES, INC. entered into DOC Amendment to Third Amended and Restated Credit Agreement with KeyBank National Association valued at $400 million term loan; borrowings repaid and revolvers terminated (effective 2024-03-01).
“On the Closing Date, upon consummation of the Mergers, Healthpeak, Healthpeak OP, DOC DR Holdco and DOC DR OP Sub executed the Consent and Third Amendment (the " DOC Amendment ") to that certain Third Amended and Restated Credit Agreement, dated as of September 24, 2021, by and among Physicians Partnership, as borrower, Physicians Realty Trust, as guarantor, the lenders party thereto and KeyBank National Association, as administrative agent”
Richard A. Weiss was appointed as Director at HEALTHPEAK PROPERTIES, INC..
“appointed John T. Thomas, Tommy G. Thompson, Pamela J. Kessler, Ava E. Lias-Booker and Richard A. Weiss to the Board, with Mr. Thomas being appointed as Vice Chair of the Board”
Ava E. Lias-Booker was appointed as Director at HEALTHPEAK PROPERTIES, INC..
“appointed John T. Thomas, Tommy G. Thompson, Pamela J. Kessler, Ava E. Lias-Booker and Richard A. Weiss to the Board, with Mr. Thomas being appointed as Vice Chair of the Board”
Pamela J. Kessler was appointed as Director at HEALTHPEAK PROPERTIES, INC..
“appointed John T. Thomas, Tommy G. Thompson, Pamela J. Kessler, Ava E. Lias-Booker and Richard A. Weiss to the Board, with Mr. Thomas being appointed as Vice Chair of the Board”
Tommy G. Thompson was appointed as Director at HEALTHPEAK PROPERTIES, INC..
“appointed John T. Thomas, Tommy G. Thompson, Pamela J. Kessler, Ava E. Lias-Booker and Richard A. Weiss to the Board, with Mr. Thomas being appointed as Vice Chair of the Board”
John T. Thomas was appointed as Vice Chair of the Board at HEALTHPEAK PROPERTIES, INC..
“appointed John T. Thomas, Tommy G. Thompson, Pamela J. Kessler, Ava E. Lias-Booker and Richard A. Weiss to the Board, with Mr. Thomas being appointed as Vice Chair of the Board”
HEALTHPEAK PROPERTIES, INC. shareholders approved Healthpeak Adjournment Proposal at the 2024-02-21 meeting.
“Proposal 3, to approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Healthpeak Common Stock Issuance Proposal and/or the Healthpeak Charter Amendment Proposal if there are insufficient votes at the time of such adjournment to approve such proposals, was approved but deemed not necessary because there was a quorum present and there were sufficient proxies at the time of the Special Meeting to approve the Healthpeak Common Stock Issuance Proposal and the Healthpeak Charter Amendment Proposal. Votes For Votes Against Abstentions Broker Non-Votes 422,711,138 45,874,415 404,236 —”
HEALTHPEAK PROPERTIES, INC. shareholders approved Healthpeak Charter Amendment Proposal at the 2024-02-21 meeting.
“Proposal 2 (the "Healthpeak Charter Amendment Proposal"), to approve an amendment to the charter of the Company to increase the authorized shares of Healthpeak common stock from a total of 750,000,000 to 1,500,000,000 shares, was approved, with the following vote counts: Votes For Votes Against Abstentions Broker Non-Votes 454,341,776 14,299,610 348,403 —”
HEALTHPEAK PROPERTIES, INC. shareholders approved Healthpeak Common Stock Issuance Proposal at the 2024-02-21 meeting.
“Proposal 1 (the "Healthpeak Common Stock Issuance Proposal"), to approve the issuance of Healthpeak common stock in connection with the transactions contemplated by the Merger Agreement, was approved, with the following vote counts: Votes For Votes Against Abstentions Broker Non-Votes 456,736,650 11,923,576 329,563 —”
HEALTHPEAK PROPERTIES, INC. reported Year Ended December 31, 2023 results: net income $304,284 thousand, EPS $0.56.
“int venture through the sale of a 65% interest in the Callan Ridge lab campus in the Torrey Pines submarket of San Diego in January 2024 – Net Debt to Adjusted EBITDAre was 5.2x for the quarter ended December 31, 2023 FULL-YEAR 2023 HIGHLIGHTS – Net income of $0.56 per share, Nareit FFO of $1.79 per share, FFO as Adjusted of $1.78 per share, AFFO of $1.53 per share, and Total Same-Store Portfolio Cash (Adjusted) NOI growth of 4.8% – Portfolio leasing summary: ▪ Full-year outpatient lease executions totaled 4.1 million square feet, with +4% cash releasing spreads on renewals ▪ Full-year lab lease executions totaled 985,000 square feet, with +23% cash releasing spreads on renewals – Development highlights: ▪ 2023 completions and new starts: ▪ Nexus on Grand: Delivered the fully leased, 148,000 square foot, $161 million lab building in South San Francisco ▪ Vantage: Delivered the fully leas”
HEALTHPEAK PROPERTIES, INC. reported Three Months Ended December 31, 2023 results: net income $70,787 thousand, EPS $0.13.
“FOURTH QUARTER 2023 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS – Net income of $0.13 per share, Nareit FFO of $0.48 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.36 per share, and Total Same-Store Portfolio Cash (Adjusted) NOI growth of 3.6% – Fourth quarter new and renewal lease executions totaled 1.1 million square feet: ▪ Outpatient Medical new and renewal lease executions totaled 743,000 square feet ▪ Lab new and renewal lease executions totaled 312,000 square feet ▪ Year-to-date 2024 Lab lease executions of 58,000 square feet with an additional 115,000 square feet under signed LOI – Received entitlements for an additional 1.3 million square feet of lab development at the Vantage campus in South San Francisco – Commenced two on-campus outpatient developments in our HCA Healthcare ("HCA") development program – Entered into a new $236 million joint venture through the sale”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.